Press release
Psoriasis Drug Market is projected to reach $56.96 billion by 2034, growing at a CAGR of 10.8% over the forecast period
Psoriasis Drug Market
Market Introduction
Medications for psoriasis are used to treat the chronic autoimmune disease known as psoriasis, which results in inflammation and scaling due to the fast development of skin cells. These medications aim to control symptoms, reduce inflammation, and slow down the turnover of skin cells. Biologic injections, oral pills, and topical therapies are all used to treat psoriasis. To assist in managing flare-ups and enhance skin health, the doctor may recommend topical corticosteroids, retinoids, immunosuppressants, biologics, or systemic therapies, depending on how severe the condition is.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/global-psoriasis-drug-market/request-for-sample
Competitive Landscape Analysis
The firms in the market provide a wide range of therapeutic alterations involving biologics, oral systemic treatments, and topical agents, serving differing patient requirements. Some of the prominent players operating in the psoriasis drug market include:
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca
• Boehringer Ingelheim International GmbH
• Celgene Corporation (a subsidiary of Bristol-Myers Squibb)
• Eli Lilly and Company
• Johnson & Johnson Services, Inc.
• LEO Pharma A/S
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.
Psoriasis Drug Market Report Highlights
• Based on class, the interleukin inhibitors segment dominates the psoriasis drug market share due to their high efficacy and safety in managing moderate-to-severe psoriasis, while ongoing innovations drive their rapid growth.
• The biologics segment, by treatment, holds the largest share and is the fastest-growing segment, driven by their targeted approach and widespread adoption for severe psoriasis cases.
• By route of administration, the parenteral segment leads the psoriasis drug market revenue share, supported by the growing use of injectable biologics, which also exhibit the highest growth due to improved delivery technologies.
• The hospital pharmacies segment, by distribution channel, dominates the market, benefiting from their role in dispensing biologics, while their growth is driven by the increasing prevalence of severe cases requiring specialized care.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/global-psoriasis-drug-market/request-for-discount-pricing
Market Drivers
Rise in Psoriasis Prevalence: The growing prevalence of psoriasis is causing a surge in market demand. As per the International Federation of Psoriasis Associations (IFPA), roughly 125 million people globally, or approximately 2-3% of the world demographics, are impacted by psoriasis. This chronic condition is associated with notable physical and psychological weight, fueling demand for effective treatment options.
Advancements in Biologics and Biosimilar Therapies: The introduction of biologics and biosimilars has transformed the market by providing targeted treatments with greater efficacy and fewer side effects as contrasted to conventional systemic drugs. Biologic therapies, especially interleukin (IL) inhibitors, and tumor necrosis factor-alpha (TNF-α) inhibitors are acquiring extensive approvals in clinical practice.
Segmentation Outlook
By Class Outlook (Revenue - USD Billion, 2020-2034)
• Tumor Necrosis Factor Inhibitors
• Interleukin Inhibitors
• Vitamin D Analogues
• Corticosteriods
• Others
By Type (Revenue - USD Billion, 2020-2034)
• Psoriatic Arthritis
• Plaque Psoriasis
• Others
By Treatment Outlook (Revenue - USD Billion, 2020-2034)
• Topicals
• Systemic
• Biologics
By Route of Administration Outlook (Revenue - USD Billion, 2020-2034)
• Oral
• Parenteral
• Topical
By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)
• Hospital Pharmacies
• Retail Pharmacies
• Others
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/global-psoriasis-drug-market
Geographical Landscape
Regionally, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
North America holds the largest psoriasis drug market share due to the high prevalence of psoriasis, advanced healthcare infrastructure, and robust adoption of biologic therapies. The region profits from notable funding in research and development, causing speedy approvals and commercialization for inventive cures.
Asia Pacific followed North America as being a significant regional market due to growing healthcare disbursement and the rising prevalanceof psoriasis in populous nations such as China and India.
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
More Trending Latest Reports by Polaris Market Research:
Brain Monitoring Market
https://www.polarismarketresearch.com/industry-analysis/brain-monitoring-market
Healthcare Supply Chain Management Market
https://www.polarismarketresearch.com/industry-analysis/healthcare-supply-chain-management-market
Molecular Infectious Disease Testing Market
https://www.polarismarketresearch.com/industry-analysis/molecular-infectious-disease-testing-market
Mental Health Teletherapy Platform Solutions Market
https://www.polarismarketresearch.com/industry-analysis/mental-health-teletherapy-platform-solutions-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriasis Drug Market is projected to reach $56.96 billion by 2034, growing at a CAGR of 10.8% over the forecast period here
News-ID: 3951648 • Views: …
More Releases from Polaris Market Research & Consulting
Orthodontic Headgear Market Size, Status, Global Outlook 2025 To 2034 | 3M Compa …
The quantitative market research report published by Polaris Market Research on Orthodontic Headgear Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Orthodontic Headgear market size, financial data, and projected future growth. All the information presented…
Gene Therapy Media Market on Track for USD 477.04 Million By 2034, Growing at a …
The quantitative market research report published by Polaris Market Research on Gene Therapy Media Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Gene Therapy Media market size, financial data, and projected future growth. All the…
Enzyme Immunoassay Market Poised to Reach USD 25.26 Billion by 2034, Growing at …
The quantitative market research report published by Polaris Market Research on Enzyme Immunoassay Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Enzyme Immunoassay market size, financial data, and projected future growth. All the information presented…
Pet Therapeutic Diet Market Forecast 2025-2034: Growth Dynamics and Competitive …
The quantitative market research report published by Polaris Market Research on Pet Therapeutic Diet Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Pet Therapeutic Diet market size, financial data, and projected future growth. All the…
More Releases for Psoriasis
Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psori …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual…
Psoriasis Vulgaris Market
Introduction
Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome.
The global psoriasis vulgaris…
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Psoriasis Market Size During the Forecast Period?
The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a…
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to…
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It…
